Primary Job Title Chief Executive Officer Primary Organization 
Cyclacel Pharmaceuticals
Gender Male
LinkedIn View on LinkedIn
Spiro Rombotis is the chief executive officer of Cyclacel Pharmaceuticals, a provider of oral therapies for the treatment of cancer and other critical diseases.
Rombotis holds a bachelor’s degree in economics from Williams College and master’s degree in business administration from Northwestern University.
Rombotis lives in London, United
Kingdom.
